In bipolar II disorder, should lamotrigine 200 mg be taken once daily or divided into twice‑daily doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lamotrigine 200mg Dosing in Bipolar II Disorder

Lamotrigine 200 mg should be taken once daily for bipolar II disorder. This is the standard maintenance dosing regimen established in clinical trials and clinical practice 1, 2.

Dosing Schedule

The target maintenance dose of 200 mg/day is achieved through slow titration over 6 weeks to minimize the risk of serious rash, including Stevens-Johnson syndrome 1, 2. This single daily dose is the standard approach used in the pivotal trials that demonstrated lamotrigine's efficacy in bipolar disorder.

Key Dosing Considerations:

  • Standard dose: 200 mg once daily (after titration)
  • With valproate: Reduce to 100 mg/day due to drug interactions that increase lamotrigine levels 3, 1
  • With enzyme inducers (e.g., carbamazepine): May increase up to 400 mg/day 3, 1

Evidence for Lamotrigine in Bipolar II

While most robust evidence comes from bipolar I disorder studies, emerging evidence supports lamotrigine's efficacy specifically in bipolar II disorder 4. A clinical study of 123 bipolar II patients showed that those achieving at least 75 mg of lamotrigine reported improvements in depressive and hypomanic episode patterns, as well as functioning across multiple domains 4.

Lamotrigine is particularly effective for preventing depressive episodes, which dominate the clinical picture of bipolar II disorder 5, 3, 6. Recent meta-analyses confirm that lamotrigine as add-on treatment significantly reduces depressive symptomatology compared to placebo (SMD -0.30, p = 0.004) and reduces relapse/recurrence rates as maintenance treatment (RR 0.84, p = 0.037) 6.

Important Safety Considerations:

  • Serious rash risk: 0.1% incidence in bipolar disorder studies 1, 2
  • Slow titration is mandatory to minimize rash risk
  • Does not cause weight gain, unlike many other mood stabilizers 1, 2
  • No routine serum level monitoring required, unlike lithium 1

Clinical Caveat:

The evidence base for bipolar II disorder specifically remains limited, with very low certainty evidence according to recent systematic reviews 7. However, the once-daily 200 mg dosing regimen is well-established from bipolar I studies and has shown promise in bipolar II populations, particularly for preventing depressive episodes which are the predominant feature of this condition 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.